142 related articles for article (PubMed ID: 30461036)
41. Suspected acute myocardial infarction in a dystrophin-deficient dog.
Schneider SM; Coleman AE; Guo LJ; Tou S; Keene BW; Kornegay JN
Neuromuscul Disord; 2016 Jun; 26(6):361-6. PubMed ID: 27105608
[TBL] [Abstract][Full Text] [Related]
42. The electroretinographic phenotype of dogs with Golden Retriever muscular dystrophy.
Beltran WA; Chahory S; Gnirs K; Escriou C; Blot S; Clerc B
Vet Ophthalmol; 2001 Dec; 4(4):277-82. PubMed ID: 11906664
[TBL] [Abstract][Full Text] [Related]
43. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies.
Banks GB; Chamberlain JS
Curr Top Dev Biol; 2008; 84():431-53. PubMed ID: 19186250
[TBL] [Abstract][Full Text] [Related]
44. Profiles of Steroid Hormones in Canine X-Linked Muscular Dystrophy via Stable Isotope Dilution LC-MS/MS.
Martins-Júnior HA; Simas RC; Brolio MP; Ferreira CR; Perecin F; Nogueira Gde P; Miglino MA; Martins DS; Eberlin MN; Ambrósio CE
PLoS One; 2015; 10(5):e0126585. PubMed ID: 26010907
[TBL] [Abstract][Full Text] [Related]
45. Muscle lesions associated with dystrophin deficiency in neonatal golden retriever puppies.
Nguyen F; Cherel Y; Guigand L; Goubault-Leroux I; Wyers M
J Comp Pathol; 2002; 126(2-3):100-8. PubMed ID: 11944998
[TBL] [Abstract][Full Text] [Related]
46. Altered myofilament structure and function in dogs with Duchenne muscular dystrophy cardiomyopathy.
Ait Mou Y; Lacampagne A; Irving T; Scheuermann V; Blot S; Ghaleh B; de Tombe PP; Cazorla O
J Mol Cell Cardiol; 2018 Jan; 114():345-353. PubMed ID: 29275006
[TBL] [Abstract][Full Text] [Related]
47. Morphological and ultrastructural evaluation of the golden retriever muscular dystrophy trachea, lungs, and diaphragm muscle.
Lessa TB; de Abreu DK; Rodrigues MN; Brólio MP; Miglino MA; Ambrósio CE
Microsc Res Tech; 2014 Nov; 77(11):857-61. PubMed ID: 25081087
[TBL] [Abstract][Full Text] [Related]
48. Radiographic features of Golden Retriever muscular dystrophy.
Brumitt JW; Essman SC; Kornegay JN; Graham JP; Weber WJ; Berry CR
Vet Radiol Ultrasound; 2006; 47(6):574-80. PubMed ID: 17153067
[TBL] [Abstract][Full Text] [Related]
49. Serum profiling identifies novel muscle miRNA and cardiomyopathy-related miRNA biomarkers in Golden Retriever muscular dystrophy dogs and Duchenne muscular dystrophy patients.
Jeanson-Leh L; Lameth J; Krimi S; Buisset J; Amor F; Le Guiner C; Barthélémy I; Servais L; Blot S; Voit T; Israeli D
Am J Pathol; 2014 Nov; 184(11):2885-98. PubMed ID: 25194663
[TBL] [Abstract][Full Text] [Related]
50. Aldehyde dehydrogenases contribute to skeletal muscle homeostasis in healthy, aging, and Duchenne muscular dystrophy patients.
Etienne J; Joanne P; Catelain C; Riveron S; Bayer AC; Lafable J; Punzon I; Blot S; Agbulut O; Vilquin JT
J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):1047-1069. PubMed ID: 32157826
[TBL] [Abstract][Full Text] [Related]
51. Respiratory dysfunction in unsedated dogs with golden retriever muscular dystrophy.
DeVanna JC; Kornegay JN; Bogan DJ; Bogan JR; Dow JL; Hawkins EC
Neuromuscul Disord; 2014 Jan; 24(1):63-73. PubMed ID: 24295812
[TBL] [Abstract][Full Text] [Related]
52. Immunophenotyping lymphocyte and acute phase proteins in canine X-linked muscular dystrophy.
Abreu DK; Monteiro JM; Souza CC; Karam RG; Fernandes RA; Lessa TB; Fagliari JJ; Miglino MA; Ambrosio CE
An Acad Bras Cienc; 2018 Sep; 90(3):2977-2990. PubMed ID: 30304229
[TBL] [Abstract][Full Text] [Related]
53. Microvessel density in muscles of dogs with golden retriever muscular dystrophy.
Nguyen F; Guigand L; Goubault-Leroux I; Wyers M; Cherel Y
Neuromuscul Disord; 2005 Feb; 15(2):154-63. PubMed ID: 15694137
[TBL] [Abstract][Full Text] [Related]
54. Effects of prednisone in canine muscular dystrophy.
Liu JM; Okamura CS; Bogan DJ; Bogan JR; Childers MK; Kornegay JN
Muscle Nerve; 2004 Dec; 30(6):767-73. PubMed ID: 15468337
[TBL] [Abstract][Full Text] [Related]
55. Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures.
Kornegay JN; Bogan DJ; Bogan JR; Dow JL; Wang J; Fan Z; Liu N; Warsing LC; Grange RW; Ahn M; Balog-Alvarez CJ; Cotten SW; Willis MS; Brinkmeyer-Langford C; Zhu H; Palandra J; Morris CA; Styner MA; Wagner KR
Skelet Muscle; 2016; 6():14. PubMed ID: 27047655
[TBL] [Abstract][Full Text] [Related]
56. Ringo: discordance between the molecular and clinical manifestation in a golden retriever muscular dystrophy dog.
Zucconi E; Valadares MC; Vieira NM; Bueno CR; Secco M; Jazedje T; da Silva HC; Vainzof M; Zatz M
Neuromuscul Disord; 2010 Jan; 20(1):64-70. PubMed ID: 19944604
[TBL] [Abstract][Full Text] [Related]
57. Musculoskeletal magnetic resonance imaging in the DE50-MD dog model of Duchenne muscular dystrophy.
Hornby NL; Drees R; Harron R; Chang R; Wells DJ; Piercy RJ
Neuromuscul Disord; 2021 Aug; 31(8):736-751. PubMed ID: 34384671
[TBL] [Abstract][Full Text] [Related]
58. Abnormal carbohydrate metabolism in a canine model for muscular dystrophy.
Amaral AR; Brunetto MA; Brólio MP; Cima DS; Miglino MA; Santos JPF; Ambrósio CE
J Nutr Sci; 2017; 6():e57. PubMed ID: 29209496
[TBL] [Abstract][Full Text] [Related]
59. Effects of an immunosuppressive treatment in the GRMD dog model of Duchenne muscular dystrophy.
Barthélémy I; Uriarte A; Drougard C; Unterfinger Y; Thibaud JL; Blot S
PLoS One; 2012; 7(11):e48478. PubMed ID: 23185260
[TBL] [Abstract][Full Text] [Related]
60. A normal life without muscle dystrophin.
Zatz M; Vieira NM; Zucconi E; Pelatti M; Gomes J; Vainzof M; Martins-Bach AB; Garcia Otaduy MC; Bento dos Santos G; Amaro E; Landini V; Andrade T
Neuromuscul Disord; 2015 May; 25(5):371-4. PubMed ID: 25770920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
